These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2563637)

  • 21. Effects of dietary modulations of protein intake on the progression of glomerulosclerosis in unilaterally nephrectomized rats with passive Heymann nephritis.
    Kawaguchi H; Yamaguchi Y; Hattori M; Nagata M; Nagata M; Kohno M; Itoh K
    Nephron; 1988; 50(3):233-46. PubMed ID: 3265761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of monoclonal antibodies against different protein and carbohydrate epitopes of dipeptidyl peptidase IV from rat liver plasma membranes.
    Hartel-Schenk S; Loch N; Zimmermann M; Reutter W
    Eur J Biochem; 1991 Mar; 196(2):349-55. PubMed ID: 1706662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis.
    Miettinen A; Törnroth T; Ekblom P; Virtanen I; Linder E
    Lab Invest; 1984 Apr; 50(4):435-46. PubMed ID: 6708453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
    Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
    Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative immunohistochemistry and histochemistry of dipeptidyl peptidase IV in rat organs during development.
    Hartel-Schenk S; Gossrau R; Reutter W
    Histochem J; 1990 Oct; 22(10):567-78. PubMed ID: 1981214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The specificity of nephritogenic antibodies. III. Binding of anti-Fx1A antibodies in glomeruli is dependent on dual specificity.
    Bagchus WM; Vos JT; Hoedemaeker PJ; Bakker WW
    Clin Exp Immunol; 1986 Mar; 63(3):639-47. PubMed ID: 3519014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative immunogold localization of dipeptidyl peptidase IV (DPP IV) in rat liver cells.
    Fukui Y; Yamamoto A; Kyoden T; Kato K; Tashiro Y
    Cell Struct Funct; 1990 Apr; 15(2):117-25. PubMed ID: 1972662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype rats.
    Retlich S; Withopf B; Greischel A; Staab A; Jaehde U; Fuchs H
    Biopharm Drug Dispos; 2009 Nov; 30(8):422-36. PubMed ID: 19771584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic evidence for role of DPP IV in intestinal hydrolysis and assimilation of prolyl peptides.
    Tiruppathi C; Miyamoto Y; Ganapathy V; Leibach FH
    Am J Physiol; 1993 Jul; 265(1 Pt 1):G81-9. PubMed ID: 8101699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
    Nakazawa M; Emancipator SN; Lamm ME
    J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heymann nephritis in Lewis rats.
    Wang YM; Lee VWS; Wu H; Harris DCH; Alexander SI
    Curr Protoc Immunol; 2015 Apr; 109():15.29.1-15.29.6. PubMed ID: 25845564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strain.
    Watanabe Y; Kojima T; Fujimoto Y
    Experientia; 1987 Apr; 43(4):400-1. PubMed ID: 2883023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.
    Schiller B; He C; Salant DJ; Lim A; Alexander JJ; Quigg RJ
    J Exp Med; 1998 Oct; 188(7):1353-8. PubMed ID: 9763614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of the development of experimental membranous nephropathy.
    Gabbai FB; Gushwa LC; Wilson CB; Blantz RC
    Kidney Int; 1987 Jun; 31(6):1267-78. PubMed ID: 3613404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effect of passive Heymann nephritis on renal blood flow and glomerular filtration rate in the rat: role of the anaphylatoxin C5a and the alpha-adrenergic nervous system.
    Sekse I; Iversen BM; Daha MR; Ofstad J
    Nephron; 1992; 60(4):453-9. PubMed ID: 1316560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal blood flow and glomerular filtration rate during the heterologous phase in passive Heymann nephritis in rats.
    Sekse I; Iversen BM; Mørkrid L; Ofstad J
    Nephron; 1990; 56(2):194-200. PubMed ID: 2243576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.
    van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E
    Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats.
    Shah SV
    Am J Physiol; 1988 Mar; 254(3 Pt 2):F337-44. PubMed ID: 2831737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
    J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.